Amyloidosis — Trials · CancerIndex

Clinical trials

Registered studies

47 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 33%
Top sponsor: Alexion Pharmaceuticals, Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02909036	Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.	active not recruiting	Phase 1	46	Memorial Sloan Kettering Cancer CenterOTHER	1	Oct 10, 2025	clinicaltrials

Data updated 22 days agoSource updated Oct 10, 2025source: clinicaltrials